Trial · NCT00003830
Results by group22
Each measurement the trial posted, group by group, in the words and numbers it posted.
1 to 20 of 22
Download this page as JSON| Outcome | Group | Category | Value | Spread | Units |
|---|---|---|---|---|---|
| Morbidity - Number of Participants With Residual Shoulder Abduction Deficit | Arm I:Sentinel Node Resection+Conventional Axillary Dissection | 276 | Participants | ||
| Morbidity - Number of Participants With Residual Shoulder Abduction Deficit | Arm II: Sentinel Node Resection Followed by Node Examination | 200 | Participants | ||
| Morbidity - Number of Participants With Residual Arm Volume Difference | Arm I:Sentinel Node Resection+Conventional Axillary Dissection | 314 | Participants | ||
| Morbidity - Number of Participants With Residual Arm Volume Difference | Arm II: Sentinel Node Resection Followed by Node Examination | 192 | Participants | ||
| Morbidity - Number of Participants With Residual Arm Numbness | Arm I:Sentinel Node Resection+Conventional Axillary Dissection | 408 | Participants | ||
| Morbidity - Number of Participants With Residual Arm Numbness | Arm II: Sentinel Node Resection Followed by Node Examination | 103 | Participants | ||
| Morbidity - Number of Participants With Residual Arm Tingling | Arm I:Sentinel Node Resection+Conventional Axillary Dissection | 175 | Participants | ||
| Morbidity - Number of Participants With Residual Arm Tingling | Arm II: Sentinel Node Resection Followed by Node Examination | 90 | Participants | ||
| Overall Survival | Arm I:Sentinel Node Resection+Conventional Axillary Dissection | 91.8 | 95% Confidence Interval 90.4 to 93.3 | percentage of patients alive at 8 years | |
| Overall Survival | Arm II: Sentinel Node Resection Followed by Node Examination | 90.3 | 95% Confidence Interval 88.8 to 91.8 | percentage of patients alive at 8 years | |
| Disease-free Survival as Measured by Breast Cancer Recurrence, Any Second Primary Cancer, and Death From Any Cause in Patients Without a Prior Event. | Arm I:Sentinel Node Resection+Conventional Axillary Dissection | 82.4 | 95% Confidence Interval 80.5 to 84.4 | percentage pts disease free at 8 years | |
| Disease-free Survival as Measured by Breast Cancer Recurrence, Any Second Primary Cancer, and Death From Any Cause in Patients Without a Prior Event. | Arm II: Sentinel Node Resection Followed by Node Examination | 81.5 | 95% Confidence Interval 79.6 to 83.4 | percentage pts disease free at 8 years | |
| Pathology Investigation of Sentinel Nodes in Sentinel Node Negative Patients to Identify a Group Who Were Potentially at Increased Risk of Systemic Recurrence | Group 1: Negative Node Patients Without Occult Metastases | 92.5 | percentage of patients | ||
| Pathology Investigation of Sentinel Nodes in Sentinel Node Negative Patients to Identify a Group Who Were Potentially at Increased Risk of Systemic Recurrence | Group 2: Negative Node Patients With Occult Metastases | 89.7 | percentage of patients | ||
| Pathology Investigation of Sentinel Nodes in Sentinel Node Negative Patients to Identify a Group Who Were Potentially at Increased Risk of Systemic Recurrence | Group 1: Negative Node Patients Without Occult Metastases | 92.5 | percentage distant disease free at 5 yrs | ||
| Pathology Investigation of Sentinel Nodes in Sentinel Node Negative Patients to Identify a Group Who Were Potentially at Increased Risk of Systemic Recurrence | Group 2: Negative Node Patients With Occult Metastases | 89.7 | percentage distant disease free at 5 yrs | ||
| The Percentage of Technically Successful Sentinel Node Resections as Measured by the Proportion of Patients for Whom at Least One Sentinel Node is Identified. | Arm I:Sentinel Node Resection+Conventional Axillary Dissection | Success | 2672 | Participants | |
| The Percentage of Technically Successful Sentinel Node Resections as Measured by the Proportion of Patients for Whom at Least One Sentinel Node is Identified. | Arm II: Sentinel Node Resection Followed by Node Examination | Success | 2707 | Participants | |
| The Percentage of Technically Successful Sentinel Node Resections as Measured by the Proportion of Patients for Whom at Least One Sentinel Node is Identified. | Arm I:Sentinel Node Resection+Conventional Axillary Dissection | Failure | 74 | Participants | |
| The Percentage of Technically Successful Sentinel Node Resections as Measured by the Proportion of Patients for Whom at Least One Sentinel Node is Identified. | Arm II: Sentinel Node Resection Followed by Node Examination | Failure | 83 | Participants |
Source ClinicalTrials.govtrials-2026-11-12-0.4.0
Sources 3
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNone stated
- NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
- NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/trials/v1/NCT00003830/results